# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-22-026765
Filing Date
2022-10-20
Accepted
2022-10-20 16:58:49
Documents
17
Period of Report
2022-10-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | dnli-20221019.htm iXBRL | 8-K | 49089
2 | EX-1.1 | exhibit11-8xkofferdetailsu.htm | EX-1.1 | 235744
3 | EX-5.1 | exhibit51-8xkofferdetailsu.htm | EX-5.1 | 14044
4 | EX-99.1 | exhibit991-8xkofferdetails.htm | EX-99.1 | 10335
8 |  | denali_txlogox02a.jpg | GRAPHIC | 604226
9 |  | image_1a.jpg | GRAPHIC | 365942
| Complete submission text file | 0001628280-22-026765.txt |  | 1826842

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | dnli-20221019.xsd | EX-101.SCH | 1932
6 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | dnli-20221019_lab.xml | EX-101.LAB | 23832
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | dnli-20221019_pre.xml | EX-101.PRE | 12528
11 | EXTRACTED XBRL INSTANCE DOCUMENT | dnli-20221019_htm.xml | XML | 10926

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38311 | Film No.: 221321628
SIC: 2836 Biological Products, (No Diagnostic Substances)